Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of IV TP-271 in Healthy Adults
NCT03234738Phase 1Completed
- Sponsor
- Tetraphase Therapeutics
- Start
- Aug 2017
- Primary completion
- Jan 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of TP-271 in bacterial infection (5 cohorts), sponsored by Tetraphase Therapeutics. Primary endpoints: Adverse Events, Physical Exams and 3 more. Started Aug 2017; status: completed.
02
Drugs
TP-271
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT03234738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03234738.